The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Years Ended June 30, 2021 and 2020
Note 1 - Organization
Hawkeye Systems, Inc. (“the Company”), a Nevada corporation incorporated on May 15, 2018, is a technology holding company with a focus on pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure to keep civilians safe. Starting 2020, the Company began sourcing and distributing PPE (Personal Protective Equipment) and other pandemic management supplies to enterprise level customers and government agencies. The Company also looks to license & acquire technology that improves life and works with partners to develop cutting edge, “smart” products for a variety of markets.
Note 2 - Summary of Significant Accounting Policies
Basis of presentation
The accompanying financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Use of estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.
Cash
The Company considers cash in banks and other deposits with an original maturity of three months or less when purchased to be cash and cash equivalents. There were no cash equivalents as of June 30, 2021 and 2020.
Financial instruments
For certain of the Company’s financial instruments, including cash, note and interest receivable, convertible note payable, and notes payable, related party, the carrying amounts approximate their fair values due to their short maturities.
Accounts receivable and allowance for doubtful accounts
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments for services or goods. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered. The Company had no allowance for doubtful accounts at June 30, 2021 or 2020.
Inventory
Inventories, consisting of finished goods and goods in transit, are primarily accounted for using the first-in-first-out (“FIFO”) method of accounting. Inventories are measured at the lower of cost and net realizable value. The Company estimates the net realizable value of inventories based on an assessment of expected sales prices.
Property and equipment
Property and equipment are recorded at cost. Repair and maintenance costs that do not improve service potential or extend economic life are expensed as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The useful life of computer equipment is five years
Certain events or changes in circumstances may indicate that the recoverability of the carrying amount of property, plant and equipment should be assessed, including, among others, a significant decrease in market value, a significant change in the business climate in a particular market, or a current period operating or cash flow loss combined with historical losses or projected future losses. When such events or changes in circumstances are present and an impairment test is performed, we estimate the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. If the sum of the expected future cash flows is less than the carrying amount, we recognize an impairment loss. The impairment loss recognized is the amount by which the carrying amount exceeds the fair value.
Fair value measurements
When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.
Convertible financial instruments
The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.
When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.
Common stock purchase warrants and derivative financial instruments
Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.
Beneficial conversion feature
The issuance of the convertible debt generated a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, resulting in a discount on the convertible debt (recorded as a component of additional paid-in capital). The discount is amortized to interest expense over the term of the convertible debt.
Income taxes
The Company uses the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, the Company does not foresee generating taxable income in the near future and utilizing its deferred tax asset, therefore, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
A tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.
Revenue recognition
Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.
Cost of sales
Cost of sales includes inventory costs and shipping and freight expenses.
Related parties
The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.
Commitments and contingencies
The Company follows ASC 450-20, “Loss Contingencies,” to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.
Basic and diluted earnings per share
Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the years ended June 30, 2021 and 2020, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:
|
|
June 30,
2021
|
|
|
June 30,
2020
|
|
Warrants
|
|
|
3,069,329
|
|
|
|
7,047,135
|
|
Options
|
|
|
7,280,000
|
|
|
|
5,255,000
|
|
Convertible notes
|
|
|
2,000,000
|
|
|
|
1,000,000
|
|
Total possible dilutive shares
|
|
|
12,349,329
|
|
|
|
13,302,135
|
|
Stock-based compensation
Stock-based compensation to employees and non-employees consist of stock options grants, warrants to purchase common stock, and restricted shares that are recognized in the statement of operations based on their fair values at the date of grant. The fair value of share of common stock is based on the trading price of the Company’s share.
The Company calculates the fair value of option and warrant grants utilizing the Black-Scholes pricing model. Assumptions used by the Company in using the Black-Scholes pricing model include: 1) volatility based on the Company’s average volatility rate, 2) risk free interest rate based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of the grant, 3) the expected life of the option or warrants, and 4) expected cash dividend rate on shares of common stock. During the year ending June 30, 2021 and 2020, volatility was based on average rates for similar publicly traded companies.
The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. The resulting stock-based compensation expense for employee awards is generally recognized on a straight- line basis over the vesting period of the award.
Reclassifications
Certain prior period amounts have been reclassified to conform with the current year presentation.
Recent accounting pronouncements
In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements.
Note 3 - Going Concern
The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the year ended June 30, 2021, the Company had a net loss of $4,741,833. As of June 30, 2021, the Company had an accumulated deficit of $9,251,674. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.
In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.
There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Note 4 – Inventory
Inventory at June 30, 2021 and 2020 consist of the following:
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
|
|
|
|
|
Finished goods
|
|
$
|
-
|
|
|
$
|
545,112
|
|
Goods in transit
|
|
|
-
|
|
|
|
90,405
|
|
Less: Obsolescence
|
|
|
-
|
|
|
|
(126,000
|
)
|
Inventory, net
|
|
$
|
-
|
|
|
$
|
509,517
|
|
During the year ended June 30, 2021 and 2020, the Company wrote off of inventories of $883,473 and $126,000, respectively.
Note 5 – Advances to Radiant Images, Inc.
Advances to Radiant Images, Inc.
Radiant Images, Inc.
On September 19, 2019, the Company entered into a Stock Purchase Agreement (“Radiant Agreement”) with Radiant Images, Inc., a California corporation (“Radiant”), as well as Radiant’s shareholder Gianna Wolfe and key employee, Michael Mansouri, pursuant to which the Company would acquire 100% of the shares of common stock of Radiant from Wolfe, effectuating the acquisition of Radiant.
Prior to the entering the agreement, Optical Flow had advanced $920,800 to Radiant. Per terms of the Radiant Agreement, this advance was to be applied as deposit on the purchase price. At June 30, 2019, the advance amount was presented as “Advances to Radiant Images, Inc.” on the consolidated balance sheet.
The Radiant purchase price was equal to $1,810,905 plus the cash and cash equivalents of Radiant as of the close of business on the closing date. The closing was anticipated to occur before December 31, 2019. Prior to closing, Hawkeye was required to have received at least $1,500,000 from the sale of equity securities.
During the year ended June 30, 2020, the Company issued a total 520,000 shares of common stock with a fair value of $260,000 to Wolfe and Mansouri. In addition, a total of 250,000 options to purchase common shares at an exercise price of $0.50 were granted to the two individuals. The fair value of the options was $125,000 and were recorded as stock based compensation. These shares and options will be cancelled.
As of June 30, 2021 and 2020, advances to Radiant was $0.
Note Receivable – Radiant Images, Inc.
In contemplation of the closing of the Radiant Agreement, the advance balance of $920,800 was formalized in a secured revolving promissory note (“Radiant Note)” dated April 26, 2019. Further advances to Radiant prior to the closing of the acquisition would increase the balance of the promissory note. The interest rate on the note was 12% and accrues daily on the outstanding balance and is collateralized by all of the assets of Radiant pursuant to a Security Agreement. The purchase price would be offset by the balance of the promissory note and interest upon closing. Through June 30, 2020, additional cash advances under the note receivable was $385,000 in equity-related transactions.
In April 2020, the Company received notice from Radiant of its intent to terminate the Radiant Agreement. As per terms of the agreement, the Radiant Note and related interest became due. The Company has ceased further discussions with respect to the acquisition and is pursuing litigation for repayment of amounts due by Radiant. The Company’s investment in Radiant was structured as a revolving note and has been classified as a Note Receivable from Radiant due with accrued but unpaid interest. Pursuant to the terms of the revolving note, Radiant is required to repay the money already invested to Hawkeye with interest. The note receivable was issued on April 26, 2019, is due upon demand of the Company at any time commencing April 26, 2020. The interest rate on the note is 12% and accrues daily on the outstanding balance. During the fiscal year ended June 30, 2020, total contributions of $337,000 were made to Radiant, bringing the balance of the note receivable to $1,305,800 at June 30, 2020 (not including interest). Because of the ongoing litigation with Radiant, the Company recorded an allowance for note receivable of $1,305,800 and interest receivable of $154,042, during the year ended June 30, 2020. Nevertheless, the Company intends to vigorously pursue the litigation and expects to fully collect these amounts from Radiant and/or its principals.
As of June 30, 2021 and 2020, note receivable and interest receivable are as follows;
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
|
|
|
|
|
Note receivable
|
|
$
|
1,305,800
|
|
|
$
|
1,305,800
|
|
Interest receivable
|
|
|
154,042
|
|
|
|
154,042
|
|
|
|
|
1,459,842
|
|
|
|
1,459,842
|
|
|
|
|
|
|
|
|
|
|
Allowance for note receivable
|
|
|
(1,305,800
|
)
|
|
|
(1,305,800
|
)
|
Allowance for interest receivable
|
|
|
(154,042
|
)
|
|
|
(154,042
|
)
|
Note 6 - Notes Payable – Related Parties
On June 13, 2019, the Company entered into a Securities Purchase Agreement with a shareholder pursuant to which it issued a Promissory Note for $200,000 due on the second anniversary of issuance. The note bears interest at 10%. In connection with the Securities Purchase Agreement, the Company issued 100,000 shares of its common stock and a warrant to purchase 400,000 shares at $1.50 per share exercisable for two years from issuance.
On June 13, 2020, the note matured, became due on demand and as a condition of maturity became convertible with a 40% discount to market price, but not lower than $1.00 per share.
On July 1, 2020, the Company and note holder agreed to convert the note of $200,000 into 800,000 shares of common stock and accrued interest of $20,932 was forgiven. As a result, the Company reclassed note payable – related party of $200,000 to common stock payable – related party and recorded debt forgiveness of $20,932 as additional paid in capital.
During the years ended June 30, 2021 and 2020, interest expense of $0 and $20,000 was recognized on this note payable – related party, respectively. Accrued interest payable, included in accounts payable and accrued liabilities, was $0 and $20,932 at June 30, 2021 and 2020, respectively.
Note 7 - Convertible Notes Payable
Convertible note
On March 17, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities LLC pursuant to which the Company issued a 10% Convertible Redeemable Note (“Convertible Note”) for the original principal amount of $150,000. The Convertible Note is due on March 17, 2021 and on the sixth month anniversary of the Note may be converted into shares of Common Stock of the Company at a 40% discount to the lowest Volume Weighted Average Price for the Company’s common stock for the 15 days preceding the conversion. The Company will recognize the derivative liability when the Note becomes convertible. The Convertible Note may be prepaid prior to the six-month anniversary at 115% of the face if paid within 30 days, and an additional 5% every 30 days thereafter with a cap of 140%. Interest accrual and debt amortization would have begun in April 2020.
Financing fees associated with the note totaled $16,500 resulting in net proceeds to the Company of $133,500. The financing fees were recognized as a discount on debt is being amortized over the term of the note.
On August 4, 2020, the note of $150,000 and accrued interest of $5,708 were converted into 469,623 shares of common stock resulting in a loss of settlement of debt totaling $370,269.
During the year ended June 30, 2021 and 2020, amortization of $12,375 and $4,125 was recognized as interest expense, respectively. As of June 30, 2021 and 2020, the balance of the note payable is $0 and $150,000 less unamortized debt discount of $0 and $12,375 or $0 and $137,625. respectively. Interest expense of $1,958 and $3,750 was recognized on the convertible note during the years ended June 30, 2021 and 2020, respectively.
Convertible note – related party
On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on April 6, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.
On December 15, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on December 15, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2021. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.
During the years ended June 30, 2021 and 2020, amortization of $119,763 and $12,899 was recognized as interest expense, respectively. As of June 30, 2021 and 2020, the balance of the note payable is $500,000 and $250,000 less unamortized debt discount of $49,067 and $38,695 or $450,933 and $211,305, respectively. Interest expense of $72,917 and $6,250 was recognized on the convertible notes during the years ended June 30, 2021 and 2020, respectively.
Note 8 – Common stock payable
As of June 30, 2021 and 2020, common stock payable are as follows:
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
Purchase of inventory – related party
|
|
$
|
-
|
|
|
$
|
153,000
|
|
Related parties
|
|
|
477,000
|
|
|
|
277,000
|
|
Commitments
|
|
|
-
|
|
|
|
6,000
|
|
|
|
$
|
477,000
|
|
|
$
|
436,000
|
|
Note 9 - Stockholders’ Equity
Common Stock
2021 Stock Issuances
During the year ended June 30, 2021, the Company had the following common stock transactions:
|
•
|
Issued 469,623 shares of common stock in exchange for conversion of debt and accrued interest of $525,978.
|
|
•
|
Issued 175,000 shares of common stock associated with the exercise of warrants for $67,500.
|
|
•
|
Issued 425,000 shares of common stock for stock subscriptions of $139,500 received prior to June 30, 2020.
|
|
•
|
Issued 515,000 shares of common stock in exchange for settlement of $180,000 in accrued salary to our CEO.
|
|
•
|
Issued 100,000 units consisting of: (i) 100,000 shares of common stock, and (ii) 100,000 options that are exercisable for 2 years for an exercise price of $0.25 per share. The purchase was at $0.20 per unit, for a total purchase price of $20,000.
|
|
•
|
Issued 668,489 shares of common stock for common stock payable of $162,000
|
|
•
|
Issued 740,000 shares of common stock for service of $146,560 to related parties
|
2020 Stock Issuances
During the year ended June 30, 2020, the Company had the following common stock transactions:
|
·
|
Sold 1,782,666 shares of its common stock for total cash proceeds of $393,000. Included with these issuances were warrants to purchase up to 4,939,635 shares at exercise prices of $0.50 and $2.50.
|
|
·
|
Issued 984,253 shares of its common stock with total value of $471,476 as compensation for salary, accounting, legal and advisory services.
|
|
·
|
Issued 400,000 shares of its common stock in exchange for convertible note payable with a value of $200,000 (see Note 7).
|
|
·
|
Issued 516,000 shares of its common stock upon exercise of warrants for $221,000 in cash.
|
|
·
|
Issued 53,333 shares of its common stock associated with the exercise of warrants for $16,000 for services.
|
|
·
|
Issued 430,000 shares of common stock for stock subscriptions of $170,000 received prior to June 30, 2019.
|
|
·
|
Issued a total of 704,668 shares of its common stock with a value of $207,000 for transactions with Radiant.
|
|
·
|
Issued 60,000 shares of common stock to replace lost shares.
|
Common Stock to be Issued
As of June 30, 2021 and 2020, the Company received payment for unissued capital stock resulting in 0 and 425,000 share of common stock to be issued for payments of $0 and $139,500, respectively.
Balance at June 30, 2019
|
|
$
|
170,000
|
|
Received on subscription
|
|
|
139,500
|
|
Common stock certificates issued
|
|
|
(170,000
|
)
|
Balance at June 30, 2020
|
|
|
139,500
|
|
Received on subscription
|
|
|
-
|
|
Common stock certificates issued
|
|
|
(139,500
|
)
|
Balance at June 30, 2021
|
|
$
|
-
|
|
Stock Purchase Warrants
Transactions in stock purchase warrants for the years ended June 30, 2021 and 2020 are as follows:
|
|
Number of
|
|
|
Weighted Average
|
|
|
|
Warrants
|
|
|
Exercise Price
|
|
Balance at June 30, 2019
|
|
|
14,655,654
|
|
|
$
|
1.14
|
|
Granted
|
|
|
5,567,137
|
|
|
|
1.40
|
|
Exercised – shares issued
|
|
|
(1,051,001
|
)
|
|
|
0.44
|
|
Exercised – subscription received
|
|
|
(300,000
|
)
|
|
|
0.30
|
|
Expired – subscription received
|
|
|
(11,824,655
|
)
|
|
|
1.12
|
|
Balance at June 30, 2020
|
|
|
7,047,135
|
|
|
|
1.52
|
|
Granted
|
|
|
2,278,996
|
|
|
|
1.06
|
|
Exercised – shares issued
|
|
|
(175,000
|
)
|
|
|
0.39
|
|
Expired
|
|
|
(6,081,802
|
)
|
|
|
1.60
|
|
Balance at June 30, 2021
|
|
|
3,069,329
|
|
|
$
|
2.27
|
|
The intrinsic value of the warrants as of June 30, 2021 is $0. All of the outstanding warrants are exercisable as of June 30, 2021.
During the year ended June 30, 2021, the Company issued 2,278,996 warrants to purchase common stock. The fair value of the warrants was determined using the Black-Scholes option pricing model with the following assumptions:
|
|
Year ended
June 30,
2021
|
|
|
Year ended
June 30,
2020
|
|
Exercise price
|
|
$ 0.30 to 2.00
|
|
|
$
|
1.00
|
|
Expected term (in years)
|
|
0.04 – 2.00 years
|
|
|
1.00 years
|
|
Risk-free rate
|
|
0.12–0.17
|
%
|
|
0.13to0.18
|
%
|
Volatility
|
|
440-660
|
%
|
|
111to190
|
%
|
Dividend yield
|
|
|
-
|
|
|
|
-
|
|
Stock Options
During 2019, the Company’s board of directors approved the 2019 Directors, Officers, Employees and Consultants Stock Option Plan (“Option Plan”) which authorized the issuance of options to purchase up to 2,500,000 shares of common stock to its employees directors, and consultants.
During the year ended June 30, 2021, pursuant the Company’s Option Plan, the Company granted 2,125,000 stock options with exercise prices of a range from $0.10 to $0.30 and a term of two or five years. These options vested immediately or 20% immediately upon issuance of this option and an additional 20% every three months thereafter. The fair value of these shares was $369,979 of which $127,993 was recognized in the year ended June 30, 2021. At June 30, 2021, compensation cost for non-vested options of $241,986 will be recognized over the next year.
During the year ended June 30, 2020, pursuant the Company’s Option Plan, the Company granted 3,200,000 stock options with exercise prices of $0.10 and a term of five years. These options vested 20% immediately upon issuance of this option and an additional 20% every three months thereafter. The fair value of these shares was $474,491 of which $189,797 was recognized in the year ended June 30, 2020 and $284,695 was recognized in the year ended June 30, 2021.
Also, during the year ended June 30, 2020, the Company issued 100,000 stock options with an exercise price of $0.25 with a 5-year term in connection with a sale of shares of common stock for cash. The options vested upon issuance. The fair value of the options was $433 and was recognized in the year ended June 30, 2020.
Also, during the year ended June 30, 2020, the Company issued 400,000 stock options to a related party with an exercise price of $0.50 with a 5-year term. These options vested 20% immediately upon issuance of this option and an additional 20% every three months thereafter. The fair value of the options was $121,278 of which $48,511 was recognized in the year ended June 30, 2020 and $72,767 was recognized in the year ended June 30, 2021.
During the year ended June 30, 2019, pursuant the Company’s Option Plan, the Company granted 522,000 stock options with exercise prices ranging from $0.50 to $0.55 and a term of five years. These options vested 20% immediately upon issuance of this option and an additional 20% every three months thereafter. The fair value of these shares was $650,717 of which $342,726 was recognized in the year ended June 30, 2019 and $307,991 was recognized in the year ended June 30, 2020.
The fair value of the options was determined using the Black-Scholes option pricing model with the following assumptions:
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
Trading price
|
|
$
|
0.15 - 0.55
|
|
|
$
|
0.06 - 0.47
|
|
Exercise price
|
|
$
|
0.10 - 0.30
|
|
|
$
|
0.10 - 0.50
|
|
Expected term (in years)
|
|
|
1.0 to 2.50
|
|
|
|
1.0 to 5.0
|
|
Risk-free rate
|
|
|
0.09%-0.27
|
%
|
|
|
0.19%-2.46
|
%
|
Volatility
|
|
|
235%-539
|
%
|
|
|
97%-174
|
%
|
Dividend yield
|
|
|
-
|
|
|
|
-
|
|
For options issued in the year ended June 30, 2021 and 2020, the volatility rate is based on the Company’s volatility. The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant. The Company has no history or expectation of paying cash dividends on its common stock.
Transactions in stock options for the years ended June 30, 2021 and 2020 is as follows:
|
|
|
|
|
|
|
|
Weighted average
|
|
|
|
Number of
|
|
|
Weighted average
|
|
|
remaining life
|
|
|
|
options
|
|
|
exercise price
|
|
|
(in years)
|
|
Outstanding, June 30, 2019
|
|
|
1,455,000
|
|
|
$
|
4.59
|
|
|
|
4.59
|
|
Granted
|
|
|
3,800,000
|
|
|
|
0.15
|
|
|
|
4.79
|
|
Expired or Forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding, June 30, 2020
|
|
|
5,255,000
|
|
|
|
0.25
|
|
|
|
4.28
|
|
Granted
|
|
|
2,125,000
|
|
|
|
0.16
|
|
|
|
4.86
|
|
Expired or Forfeited
|
|
|
(100,000
|
)
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding, June 30, 2021
|
|
|
7,280,000
|
|
|
|
0.23
|
|
|
|
3.76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, June 30, 2021
|
|
|
5,765,000
|
|
|
$
|
0.25
|
|
|
|
3.46
|
|
At June 30, 2021, the intrinsic value of the outstanding options was $60,500.
Note 10 – Income Taxes
The Company did not recognize a provision (benefit) for income taxes for the years ended June 30, 2021 and 2020.
At December 31, 2020 and 2019, the Company had net deferred tax assets principally arising from the net operating loss carryforward for income tax purposes multiplied by an expected federal rate of 21%. As management of the Company cannot determine that it is more likely than not that the Company will realize the benefit of the deferred tax assets, a valuation allowance equal to 100% of the net deferred tax asset exists at June 30, 2021 and 2020.
A reconciliation of the federal statutory income tax to our effective income tax is as follows:
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
Federal statutory rates
|
|
$
|
(995,785
|
)
|
|
$
|
(546,098
|
)
|
Income tax adjustment
|
|
|
|
|
|
|
|
|
Expense not deductible in current period
|
|
|
-
|
|
|
|
306,567
|
|
Permanent difference
|
|
|
343
|
|
|
|
173
|
|
Valuation allowance against net deferred tax assets
|
|
|
995,442
|
|
|
|
239,358
|
|
Effective rate
|
|
$
|
-
|
|
|
$
|
-
|
|
At June 30, 2021, the Company had federal net operating loss carry forwards of approximately $1,563,000 will never expire but its utilization is limited to 80% of taxable income in any future year.
Net deferred tax assets consist of the following components as of:
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
|
|
|
|
|
Operating loss carry forward
|
|
$
|
1,562,788
|
|
|
$
|
567,346
|
|
Valuation allowance
|
|
|
(1,562,788
|
)
|
|
|
(567,346
|
)
|
Net deferred income tax asset
|
|
$
|
-
|
|
|
$
|
-
|
|
The Company is open to examination of our income tax filings in the United States and state jurisdictions for the 2018 through 2020 tax years. Tax attributes from years prior to that can be adjusted as a result of examinations. In the event that the Company is assessed penalties and or interest, penalties will be charged to other operating expense and interest will be charged to interest expense.
Note 11 - Related Party Transactions
In addition to the notes payable described in Note 7, the Company had the following transactions with related parties:
|
·
|
On September 11, 2019, the Company elected M. Richard Cutler, the Company’s corporate and securities counselor, as a member of its board of directors. During the year ended June 30, 2020, legal expense associated with Mr. Cutler’s services totaled $377,707 of which $165,000 was paid in the form of 330,000 shares of the Company’s common stock. At June 30, 2020, the Company has an account payable to Mr. Cutler of $76,817.
|
|
|
|
|
·
|
On June 1, 2020 the Company entered into an agreement with a related party and a third party for the primary purpose of procurement, financing, transportation, sale and disposition and related matters in personal protection equipment (PPE), and all such other business incidental thereto. Pursuant to the agreement, the related party and third party paid $2,000,000 for a deposit on PPE. The balance of the $2,000,000 is payable from net profits from the venture as follows: 43.5% to the Company, 43.5% to the related party and 13.0% to the third party. Subsequent to repayment of the $2,000,000, net profits are distributed 40% to the Company, 20% to the related party and 40% to the third party.
On June 1, 2020, a related party provided $277,000 for the purchase of PPE. The related party agreed to convert $277,000 of such amount into common stock at $.25 per share. As at June 30, 2020, the Company has recorded this as amount as a common stock payable.
|
Note 12 – Commitments and Contingencies
On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. Total expense recognized under this agreement during the year ended June 30, 2020 was $70,855. At June 30, 2021 and 2020, the Company has a balance of $30,000 and $27,000 payable and $0 and $6,000 worth of common stock, respectively.
On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the year ended June 30, 2021 and 2020, compensation expense of $317,497 and $284,130 was recognized under this agreement, respectively. At June 30, 2021 and 2020, the Company has a payable due to its CEO of $0 and $150,000, respectively. The agreement contained provisions for severance, health benefits, and a car allowance.
Note 13 – Inventory Financing Payable – Related Party
On February 19, 2021, a related party advanced $1 million to the Company. The purpose of the advance is to purchase inventory to satisfy a customer order. The advance will be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The investor is 100% at risk as this is a non-recourse funding vehicle.
During the year ended June 30, 2021 the company cancelled the contemplated purchase of inventory and returned $500,000 to the related party. The related party has agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.
Note 14 - Subsequent Events
On September 24, 2021, the Company issued 300,000 shares of common stock to settle $30,000 of accounts payable.